The Meb Faber Show
The Meb Faber Show

Robin Goldstein & Daniel Sumner – The Economics of Weed | #424

Today’s guests are Robin Goldstein and Daniel Sumner, two economists and the authors of the new book, Can Legal Weed Win?: The Blunt Realities of Cannabis Economics. If you are a fan of Freakonomics, this episode is up your alley! In today’s episode, we start with the history of weed and what led to

Featured Speakers

Meb Faber HostRobin Goldstein GuestDaniel Sumner Guest

Topics Discussed

Episode Summary

Executive Summary: Economists Robin Goldstein and Daniel Sumner trace cannabis from prohibition’s racist origins to today’s fragmented legal market, arguing that heavy regulation and taxes keep legal weed expensive and noncompetitive versus illicit supply. They see premium niches, but expect commoditization, falling prices, and a federal legalization outcome that could help consumers yet hurt many current operators if layered with taxes and rules.

Main Topics: History of cannabis prohibition and legalization (Priority: 5/5): The guests explain how weed was long used medically and recreationally, then became illegal in the U.S. during the temperance era, intensified under Nixon, and partially reversed starting with California medical legalization in the 1990s and adult-use legalization in the 2010s. Why legal weed competes poorly with the illegal market (Priority: 5/5): They argue legal cannabis often costs about twice as much as illicit product, is hard to differentiate by consumption, and faces consumer incentives to buy cheaper underground supply unless convenience or legality matters. Regulation, taxes, and local control as market barriers (Priority: 5/5): The discussion highlights how state and local licensing, taxes, and local opt-outs dramatically reduce the number of legal stores and raise compliance costs, unintentionally preserving the black market. Product differentiation and premium cannabis (Priority: 4/5): They compare cannabis to beer and wine, suggesting premiumization is possible through origin, story, and cultivation methods, but most of the market will remain price-sensitive commodity demand. Sativa/indica labels and consumer information (Priority: 4/5): The guests are skeptical that sativa versus indica has real scientific meaning, arguing labels are often unreliable and consumers should rely more on direct experience and tasting than packaging claims. Federal legalization: benefits and risks (Priority: 5/5): They see federal legalization as potentially useful for banking and tax deductibility, but warn it could also bring interstate competition, federal taxes, and another layer of regulation that harms existing state operators. Forecasts for industry structure and pricing (Priority: 4/5): The guests expect efficiency gains, falling prices, and expanding quantities over time, but doubt revenue can surge indefinitely because legalization usually lowers price as much as or more than it increases volume.

Key Arguments: Cannabis prohibition was driven largely by temperance politics, racialized propaganda, and later the war on drugs rather than clear scientific evidence. Legal and illegal weed are often close substitutes; because consumers can’t easily tell them apart after purchase, price becomes the main differentiator. Heavy regulation creates scarcity, raises costs, and makes legal stores less accessible, pushing consumers and sellers back to the illicit market. Medical cannabis in many states functioned as quasi-legal adult-use cannabis, which helped the market grow before more restrictive recreational rules were imposed. Premium cannabis can exist, but the category is likely to remain a small share of volume because most consumers prioritize value and repeat purchases. Sativa/indica classifications are not reliable enough to guide consumer effects; labelling and marketing often outpace science. Federal legalization is not automatically bullish for the industry: it may help consumers and some operators, but interstate trade and federal oversight could crush higher-cost producers. The most likely long-run path is commoditization: better production, lower costs, more standardization, and falling prices. A federal approach that simply deschedules cannabis would likely be far less disruptive than one that adds federal excise taxes and licensing requirements. The U.S. could eventually become a premium or export leader, but only if it develops strong branding, origin stories, and cultivation standards.

Data Points: Origin of '420': 4:20 p.m. - Guests cite the common story that California high school kids used the time as a meetup code for smoking weed. Cannabis THC threshold for hemp: 0.3% THC - U.S. government distinction between hemp and marijuana/cannabis discussed in the interview. California dispensaries under medical system: More than 3,000 to 4,000 stores - Estimate for 2017-era medical dispensaries before adult-use rules tightened access. California retail stores under recreational system: About 1,000 stores - Estimate roughly four years after recreational legalization, reflecting higher barriers to entry. Legal vs. illegal price gap: Illegal weed costs about half as much - Core explanation for why many consumers continue to buy outside the legal market. Legal share of consumption in California: About 25% - Rough estimate of total consumption occurring through legal channels in a place like California. Yolo County cultivation tax: 4% of gross revenue - County-level tax discussed as part of the cost burden on legal growers. State cannabis tax: 15% per unit tax or $160 per pound - Example of state taxation burden on cultivation. State retail sales tax: Percentage tax on retail sales - Mentioned as an additional layer on top of cultivation taxes. Average bottle of wine in America: $6 to $7 - Used in a comparison about price sensitivity and consumer perceptions of premium products. Annual product displacement from cropland: Approximately 4.8 acres of cropland per minute - Farmland ad read arguing for farmland as an inflation hedge and scarce asset class.

Pivotal Quotes: "I think that anyone who thinks that federal legalization is just going to be a blanket win, victory, help the whole industry is either super high or not looking at the realities." — Robin Goldstein: Warning that federal legalization could create major winners and losers rather than uniformly benefiting the industry. "We think actually, although weed is more informal, it's actually more precise because it's specifically about stuff that you smoke or inhale or eat to get the effects that people associate with weed." — Daniel Sumner: Explaining why the guests prefer the term 'weed' over cannabis or marijuana in the book and podcast. "First, do no harm." — Daniel Sumner: Summary of their policy advice to federal lawmakers: avoid overregulation and unnecessary taxes.

Implications: Legal cannabis will likely keep commoditizing unless regulation eases. Consumers benefit from lower prices and freer trade, but many current licensed operators could lose out if federal legalization adds taxes and bureaucracy.

🔓 Sign Up for Unlimited Episode Search

About The Meb Faber Show

Ready to grow your wealth through smarter investing decisions? With The Meb Faber Show, bestselling author, entrepreneur, and investment fund manager, Meb Faber, brings you insights on today’s markets and the art of investing. Featuring some of the top investment professionals in the world as his guests, Meb will help you interpret global equity, bond, and commodity markets just like the pros. Whether it’s smart beta, trend following, value investing, or any other timely market topic, each week you’ll hear real market wisdom from the smartest minds in investing today. Better investing starts here. For more information on Meb, please visit MebFaber.com. For more on Cambria Investment Management, visit CambriaInvestments.com.

View all episodes from The Meb Faber Show